(S (NP (JJ Many) (JJ experimental) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (NN prion) (NN AGAAAAGA)) (NP (NN palindrome) (JJ hydrophobic) (NN region) (PRN (-LRB- -LRB-) (NP (CD 113) (SYM -) (CD 120)) (-RRB- -RRB-)))) (VP (VP (VBZ has) (NP (NP (NN amyloid) (NN fibril)) (VP (VBG forming) (NP (NNS properties))))) (CC and) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NN prion) (NNS diseases))))))))) (. .))
(S (ADVP (RB However)) (, ,) (PP (IN due) (PP (IN to) (NP (NP (DT the) (ADJP (JJ unstable) (, ,) (JJ noncrystalline) (CC and) (JJ insoluble)) (NN nature)) (PP (IN of) (NP (DT the) (NN amyloid) (NN fibril)))))) (, ,) (PP (IN to) (NP (NN date))) (NP (NP (JJ structural) (NN information)) (PP (IN on) (NP (NNP AGAAAAGA) (NN region) (PRN (-LRB- -LRB-) (NP (CD 113) (SYM -) (CD 120)) (-RRB- -RRB-))))) (VP (VBZ has) (VP (VBN been) (ADJP (RB very) (JJ limited)))) (. .))
(S (NP (DT This) (NN region)) (VP (VBZ falls) (ADVP (RB just)) (PP (IN within) (NP (NP (DT the) (ADJP (NN N) (HYPH -) (JJ terminal)) (ADJP (JJ unstructured)) (NN region) (NN PrP)) (-LRB- -LRB-) (NP (QP (CD 1) (SYM -) (CD 123))) (-RRB- -RRB-) (PP (IN of) (NP (NN prion) (NN proteins)))))) (. .))
(S (NP (NP (JJ Traditional) (NN X-ray) (NN crystallography)) (CC and) (NP (NML (JJ nuclear) (NML (JJ magnetic) (NN resonance) (PRN (-LRB- -LRB-) (NP (NN NMR)) (-RRB- -RRB-))) (NN spectroscopy)) (JJ experimental) (NNS methods))) (VP (MD can) (RB not) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB get) (NP (PRP$ its) (JJ structural) (NN information)))))))) (. .))
(S (PP (IN Under) (NP (DT this) (NN background))) (, ,) (NP (DT this) (NN paper)) (VP (VBZ introduces) (NP (NP (DT a) (JJ novel) (NN approach)) (PP (IN of) (NP (DT the) (JJ canonical) (JJ dual) (NN theory)))) (S (VP (TO to) (VP (VB address) (NP (NP (DT the) (NN 3D) (NML (JJ atomic) (HYPH -) (NN resolution)) (NN structure)) (PP (IN of) (NP (NML (NN prion) (NN AGAAAAGA)) (NN amyloid) (NNS fibrils)))))))) (. .))
(S (NP (NP (DT The) (NN novel)) (CC and) (NP (NP (ADJP (JJ powerful) (JJ canonical)) (JJ dual) (JJ computational) (NN approach)) (VP (VBN introduced) (PP (IN in) (NP (DT this) (NN paper)))))) (VP (VBZ is) (UCP (PP (IN for) (NP (NP (DT the) (JJ molecular) (NN modeling)) (PP (IN of) (NP (NML (NN prion) (NN AGAAAAGA)) (NN amyloid) (NNS fibrils))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (NP (DT the) (JJ optimal) (NML (JJ atomic) (HYPH -) (NN resolution)) (NNS structures)) (PP (IN of) (NP (NML (NN prion) (NN AGAAAAGA)) (NN amyloid) (NNS fibils)))) (VP (VBN presented) (PP (IN in) (NP (DT this) (NN paper))))) (VP (VBP are) (ADJP (JJ useful) (PP (IN for) (NP (DT the) (NN drive) (S (VP (TO to) (VP (VB find) (NP (NP (NNS treatments)) (PP (IN for) (NP (NN prion) (NNS diseases)))) (PP (IN in) (NP (NP (DT the) (NN field)) (PP (IN of) (NP (JJ medicinal) (NN chemistry)))))))))))))))) (. .))
(S (ADVP (RB Overall)) (, ,) (NP (DT this) (NN paper)) (VP (VP (VBZ presents) (NP (DT an) (JJ important) (NN method))) (CC and) (VP (VBZ provides) (NP (JJ useful) (NN information)) (PP (IN for) (NP (NP (NNS treatments)) (PP (IN of) (NP (NN prion) (NNS diseases))))))) (. .))
(S (ADVP (RB Overall)) (, ,) (NP (DT this) (NN paper)) (VP (MD could) (VP (VB be) (PP (IN of) (NP (NN interest))) (PP (IN to) (NP (NP (DT the) (JJ general) (NN readership)) (PP (IN of) (NP (NNP Theoretical) (NNP Biology))))))) (. .))
